Cargando…

Inflammatory Marker Predicts Outcome of Oral Squamous Cell Carcinoma Receiving Chemo-Radiotherapy

BACKGROUND: Inflammation is involved in the progression of oral squamous cell carcinoma. We therefore postulate that a blood-based inflammatory marker, the neutrophil-to-lymphocyte ratio, could help to predict the prognosis in patients with oral squamous cell carcinoma receiving chemo-radiotherapy,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Wei, Gao, Meng, Hu, Guangyuan, Yuan, Xun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718863/ https://www.ncbi.nlm.nih.gov/pubmed/33293860 http://dx.doi.org/10.2147/CMAR.S277927

Ejemplares similares

Assessment and prevalence of concomitant chemo-radiotherapy-induced oral mucositis in patients with oral squamous cell carcinoma
por: MINHAS, Sadia, et al.
Publicado: (2021)

Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy
por: Nayak, Seema, et al.
Publicado: (2018)

Predictive Model and Precaution for Oral Mucositis During Chemo-Radiotherapy in Nasopharyngeal Carcinoma Patients
por: Li, Pei-Jing, et al.
Publicado: (2020)

Correction: Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy
por: Nayak, Seema, et al.
Publicado: (2018)

Galectin-7 as a potential predictive marker of chemo-and/or radio-therapy resistance in oral squamous cell carcinoma
por: Matsukawa, Sho, et al.
Publicado: (2014)

Predicting response to radical (chemo)radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma
por: Lee, Jen Y, et al.
Publicado: (2017)

Role of Inflammatory Markers in Prognosis of Oral Squamous Cell Carcinoma
por: Dantas, Thinali Sousa, et al.
Publicado: (2019)

No additional prognostic value for MRE11 in squamous cell carcinomas of the anus treated with chemo-radiotherapy
por: Walker, Alexandra K, et al.
Publicado: (2018)

No additional prognostic value for MRE11 in squamous cell carcinomas of the anus treated with chemo-radiotherapy
por: Walker, Alexandra K, et al.
Publicado: (2017)

Increased Expression of Oct4, Nanog and CD24 Predicts Poor Response to Chemo-Radiotherapy and Unfavourable Prognosis in Locally Advanced Oral Squamous Cell Carcinoma
por: Mishra, Sridhar, et al.
Publicado: (2020)

Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy
por: Repetto, Ombretta, et al.
Publicado: (2017)

A phase II study of concurrent chemo-radiotherapy with weekly nedaplatin in advanced squamous cell carcinoma of the uterine cervix
por: Yuan, Guangwen, et al.
Publicado: (2014)

The Clinical Value of Measuring Circulating HPV DNA during Chemo-Radiotherapy in Squamous Cell Carcinoma of the Anus
por: Lefèvre, Anna C., et al.
Publicado: (2021)

Prognostic and Predictive Relevance of Tumor-Infiltrating Lymphocytes in Squamous Cell Head–Neck Cancer Patients Treated with Radical Radiotherapy/Chemo-Radiotherapy
por: Koukourakis, Ioannis M., et al.
Publicado: (2022)

Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy
por: Baumann, Brian C., et al.
Publicado: (2020)

Dynamic contrast-enhanced magnetic resonance imaging for pretreatment prediction of early chemo-radiotherapy response in larynx and hypopharynx carcinoma
por: Guo, Wei, et al.
Publicado: (2016)

Prognostic value of baseline (18)F-FDG PET/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy
por: Xia, Lianshuang, et al.
Publicado: (2023)

Recurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapy
por: Oksuz, Didem C, et al.
Publicado: (2011)

Accuracy of Response Assessment FDG PET-CT Post (Chemo)Radiotherapy in HPV Negative Oropharynx Squamous Cell Carcinoma
por: Iyizoba-Ebozue, Zsuzsanna, et al.
Publicado: (2022)

Clinical significance of Osaka prognostic score based on nutritional and inflammatory status in patients with esophageal squamous cell carcinoma
por: Feng, Jifeng, et al.
Publicado: (2022)

Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers
por: Deist, Timo M., et al.
Publicado: (2018)

A Nomogram to Predict Critical Weight Loss in Patients with Nasopharyngeal Carcinoma During (Chemo) Radiotherapy
por: Huang, Chen, et al.
Publicado: (2022)

Predictive Value of Early Post-Treatment Diffusion-Weighted MRI for Recurrence or Tumor Progression of Head and Neck Squamous Cell Carcinoma Treated with Chemo-Radiotherapy
por: Brenet, Esteban, et al.
Publicado: (2020)

Sarcopenia as a Prognostic Marker in Elderly Head and Neck Squamous Cell Carcinoma Patients Undergoing (Chemo-)Radiation
por: Haehl, Erik, et al.
Publicado: (2022)

Plasma-Derived Inflammatory Proteins Predict Oral Squamous Cell Carcinoma
por: Liu, Kelly Yi Ping, et al.
Publicado: (2018)

Prognostic Factors of Long-Term Outcomes after Primary Chemo-Radiotherapy in Non-Metastatic Anal Squamous Cell Carcinoma: An International Bicentric Cohort
por: Iseas, Soledad, et al.
Publicado: (2023)

Cutaneous squamous-cell carcinoma of the head-neck area refractory to chemo-radiotherapy: benefit from anti-PD-1 immunotherapy
por: Koukourakis, Ioannis M., et al.
Publicado: (2021)

The Prognostic Significance of Nomogram-Based Pretreatment Inflammatory Indicators in Patients With Esophageal Squamous Cell Carcinoma Receiving Intensity-Modulated Radiotherapy
por: Xu, Zhiyang, et al.
Publicado: (2023)

MVP expression in the prediction of clinical outcome of locally advanced oral squamous cell carcinoma patients treated with radiotherapy
por: Henríquez-Hernández, Luis Alberto, et al.
Publicado: (2012)

Nanocurcumin in Oral Squamous Cancer Cells and Its Efficacy as a Chemo-Adjuvant
por: Mukherjee, Diptasree, et al.
Publicado: (2022)

Identification of High-Risk Subgroups of Patients With Oral Cavity Cancer in Need of Postoperative Adjuvant Radiotherapy or Chemo-Radiotherapy
por: Chen, Wen-Cheng, et al.
Publicado: (2016)

The Long-Term Effects of Chemo Radiotherapy on Oral Health and Dental Development in Childhood Cancer
por: Najafi, SH., et al.
Publicado: (2011)

Chemo-radiotherapy induced oral mucositis during IMRT for head and neck cancer - An assessment
por: Nagarajan, Karthika
Publicado: (2015)

LINC00958-MYC positive feedback loop modulates resistance of head and neck squamous cell carcinoma cells to chemo- and radiotherapy in vitro
por: Huang, Shanshan, et al.
Publicado: (2019)

Predictive single nucleotide polymorphism markers for acute oral mucositis in patients with nasopharyngeal carcinoma treated with radiotherapy
por: Le, Ziyu, et al.
Publicado: (2017)

Loss of heterozygosity as a marker to predict progression of oral epithelial dysplasia to oral squamous cell carcinoma
por: Rao, Umadevi Krishna Mohan, et al.
Publicado: (2018)

CD73 as a novel marker for poor prognosis of oral squamous cell carcinoma
por: REN, ZHEN-HU, et al.
Publicado: (2016)

Successful High-Dose Radiation Treatment for Chemo-Resistant Oral Squamous Cell Carcinoma in a Kindler's Syndrome Patient
por: Kimura, Yuka, et al.
Publicado: (2021)

Feasibility of carbon‐ion radiotherapy for oral non‐squamous cell carcinomas
por: Ikawa, Hiroaki, et al.
Publicado: (2019)

Biological consequences of cancer radiotherapy in the context of oral squamous cell carcinoma
por: Feller, G., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_91rks49tpalk1lgc90rf6rjstk